Discover 468 paid clinical trials in Grand Rapids, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 468
Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers
for
Gastrointestinal Cancers
Location: Grand Rapids MI, Nashville TN, Aurora CO, Tampa FL,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07539311
Phase 2, Recruiting
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
for
Polycythemia Vera (PV), Myelofibrosis (MF),
Location: Grand Rapids MI, Nashville TN, Philadelphia PA,
Sponsor: Prelude Therapeutics Incorporated
Sex: All
Age: 18+
Code: NCT07469891
Phase 1, Recruiting
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
for
Multiple Myeloma
Location: Grand Rapids MI, Chicago IL, Newnan GA, Denver CO,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07409246
Phase 1, Recruiting
Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Grand Rapids MI, Lake Success NY, New Haven CT
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07387068
Phase 1, Recruiting
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Grand Rapids MI, New Haven CT, Boston MA,
Sponsor: Ottimo Pharma Limited
Sex: All
Age: 18+
Code: NCT07266428
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
for
Multiple Myeloma (MM)
Location: Grand Rapids MI, Louisville KY, Baltimore MD, Durham NC,
Sponsor: C4 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07280013
Phase 1, Recruiting
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
for
Advanced Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-),
Location: Grand Rapids MI, New York NY, Long Island City NY,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07318805
Phase 1, Recruiting
A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.
for
Advanced Solid Tumors
Location: Grand Rapids MI, St Louis MO, Fairfax VA, Houston TX,
Sponsor: FoRx Therapeutics AG
Sex: All
Age: 18+
Code: NCT07356453
Phase 1, Recruiting
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Grand Rapids MI, Fairfax VA, Baltimore MD, New York NY,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07349537
Phase 1, Recruiting
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
for
Liposarcoma, Prostate Cancer, Advanced Breast Cancer,
Location: Grand Rapids MI, Nashville TN, Trumbull CT,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT04557449
Phase 2, Recruiting
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
for
Neoplasm Malignant
Location: Grand Rapids MI, Ottawa, Fairfax VA, Baltimore MD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07209111
Phase 2, Recruiting
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
for
Advanced Squamous Tumors
Location: Grand Rapids MI, Chicago IL, Toronto, Huntersville NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07241039
Phase 1, Recruiting
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
for
Prostatic Neoplasms
Location: Grand Rapids MI, New York NY, Sarasota FL,
Sponsor: Janssen Research & Development, LLC
Sex: Male
Age: 18+
Code: NCT07746713
Phase 1, Recruiting
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400